Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Senior-Loken syndrome is an autosomal recessive ciliopathy characterized by nephronophthisis and early-onset retinal degeneration. Biallelic mutations in CEP290 disrupt primary cilium function in both renal tubular epithelial cells and photoreceptors, leading to progressive kidney failure and vision loss.
Inheritance is autosomal recessive. In a retrospective cohort of 74 patients with Senior-Loken syndrome, CEP290 variants accounted for 61.4% (≈46) of probands, each harboring homozygous or compound heterozygous loss-of-function or missense alleles with concordant clinical segregation ([PMID:36990420]). A representative pathogenic variant is c.4962_4963del (p.Glu1656fsTer) identified in a patient with long-standing Senior-Loken syndrome presenting with end-stage renal disease and retinitis pigmentosa ([PMID:32208788]).
The variant spectrum in Senior-Loken syndrome includes over 30 distinct alleles: nonsense, frameshift, splice-site, and rare missense changes. Recurrent deep intronic mutations (e.g., c.2991+1655A>G) induce pseudoexon inclusion and have become targets for antisense oligonucleotide–mediated splice correction in vitro.
Functional studies demonstrate that CEP290 localizes to centriolar satellites, interacting with PCM-1 to recruit Rab8 for ciliogenesis. Knockdown of CEP290 in human cells disrupts PCM-1 distribution, microtubule organization, and cilium formation, recapitulating renal and retinal defects of Senior-Loken syndrome ([PMID:18772192]). Antisense rescue of mis-splicing restores ciliation in patient fibroblasts, further validating the loss-of-function mechanism.
No conflicting evidence has been reported. Together, genetic and experimental data establish a definitive association between CEP290 and Senior-Loken syndrome.
Key Take-home: CEP290 gene sequencing and targeted splice-modulation strategies have high diagnostic and therapeutic utility in Senior-Loken syndrome.
Gene–Disease AssociationStrong≈46 probands with biallelic CEP290 variants in unrelated families demonstrating nephronophthisis and retinopathy ([PMID:36990420]); consistent autosomal recessive segregation and experimental concordance. Genetic EvidenceStrong46 probands with homozygous or compound heterozygous loss-of-function and missense variants in CEP290 under AR inheritance; reached genetic evidence cap. Functional EvidenceModerateCEP290 knockdown disrupts PCM-1/Rab8–mediated ciliogenesis in human cell models, aligning with Senior-Loken phenotypes ([PMID:18772192]). |